Medtronic plc has beta of 0.53. As returns on market increase, Medtronic plc returns are expected to increase less than the market. However during bear market, the loss on holding Medtronic plc will be expected to be smaller as well. Medtronic plc dividends can provide a clue to current valuation of the stock. The firm one year expected dividend income is about $0.97 per share. The company has Net Profit Margin of
15.15 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of
30.22 % which entails that for every 100 dollars of revenue it generated 0.3 of operating income.
There are currently many different techniques concerning forecasting the market as a whole as well as
predicting future values of individual securities such as Medtronic PLC. Regardless of method or technology, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the
market sentiment and impact your forecasting results.
Predictive Modules for Medtronic PLC
Sophisticated investors, who have witnessed
many market ups and downs, anticipate that the market will even out over time. This tendency of Medtronic PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Medtronic PLC. Your research has to be compared to or analyzed against Medtronic PLC's peers to derive any actionable benefits. When done correctly, Medtronic PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Medtronic PLC.
How important is Medtronic PLC's Liquidity
Medtronic PLC
financial leverage refers to using borrowed capital as a funding source to finance Medtronic PLC ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Medtronic PLC financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Medtronic PLC's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Medtronic PLC's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Medtronic PLC's total debt and its cash.
Medtronic PLC Gross Profit
Medtronic PLC Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Medtronic PLC previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Medtronic PLC Gross Profit growth over the last 10 years. Please check Medtronic PLC's
gross profit and other
fundamental indicators for more details.
Is Medtronic PLC valued wisely by the market?
The company reported last year revenue of 30.56B. Total Income to common stockholders was 4.63B with profit before taxes, overhead, and interest of 21.49B. The latest bullish price patterns experienced by current Medtronic plc shareholders may encourage investors to take a closer look at the firm as it closed today at a share price of
97.5 on
3792658.000 in trading volume. The company directors and management have been very successful with rebalancing the firm components at opportune times to take advantage of market volatility in
June. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.882. The very small Stock volatility is a good signal to investors with longer term investment horizons. Medtronic plc preserves 3.0 of z score. Medtronic plc is selling for under 98.02. That is 0.09 percent decrease. Day high is 98.39. Medtronic plc Current Assets is increasing over the last 4 years. Moreover, Medtronic plc Total Liabilities is comparatively stable at the moment.
In closing, we see that Medtronic plc Barely shadows market. The firm is
undervalued with
low probability of financial unrest within the next 24 months. Our prevailing 'Buy/Hold/Sell' recommendation on the firm is
Strong Buy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Medtronic PLC. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com